Clinical Trials Browser

Phase 2 × Not yet recruiting × Liver Neoplasms × Clear all

NCT06855225 2026-01-14

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Liver Neoplasms

NCT07312292 2025-12-31

RADIANT

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT06852820 2025-09-23

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06935175 2025-04-20

A Study of SHR-1826 Monotherapy or in Combination With Immunotherapy in the Treatment of Advanced Hepatocellular Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Liver Neoplasms

NCT06632522 2024-10-09

Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .

Phase 2 Not yet recruiting

Gastrointestinal

Liver Neoplasms

NCT06563947 2024-08-21

Single Arm Clinical Trial (Gut Microbiota and HCC)

Phase 2 Not yet recruiting

Gastrointestinal

Liver Neoplasms

NCT06408623 2024-05-10

Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Liver Neoplasms